Combination therapy with daily interferon alpha and ribavirin in naive patients with chronic hepatitis C.

被引：0
|
作者：
Rothstein, KD [1 ]
Suvannasankha, A [1 ]
Digreggorio, K [1 ]
Gross, F [1 ]
Peikin, S [1 ]
Mushnick, A [1 ]
Deangelo, C [1 ]
Salowe, D [1 ]
Siegel, H [1 ]
Shaw, E [1 ]
Bond, K [1 ]
Manzarbeitia, C [1 ]
机构：
[1] Albert Einstein Med Ctr, Philadelphia, PA 19141 USA
来源：
HEPATOLOGY | 1999年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1836
引用
收藏
页码：619A / 619A
页数：1
相关论文
共 50 条
  • [41] Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C
    Iwasaki, Y
    Ikeda, H
    Araki, Y
    Osawa, T
    Kita, K
    Ando, M
    Shimoe, T
    Takaguchi, K
    Hashimoto, N
    Kobatake, T
    Tomita, M
    Kawaguchi, M
    Kobashi, H
    Sakaguchi, K
    Shiratori, Y
    HEPATOLOGY, 2006, 43 (01) : 54 - 63
  • [42] Continuous combination therapy in treatment naive patients with chronic hepatitis C.
    Lawitz, EJ
    Cantu, NS
    Kadakia, SC
    HEPATOLOGY, 2001, 34 (04) : 585A - 585A
  • [43] Interferon-ribavirin combination therapy for chronic hepatitis C
    Schalm, SW
    Brouwer, JT
    Chemello, L
    Alberti, A
    Bellobuono, A
    Ideo, G
    Schwartz, R
    Weiland, O
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (12) : S131 - S134
  • [44] The response rates in hepatitis C patients on interferon alpha and interferon+ribavirin combination therapy
    Muderrisoglu, Cuneyt
    Fincanci, Muzaffer
    Izat, Aylin
    Soysal, Ferda
    Boztas, Zeki
    Eren, Gulhan
    Polat, Hayri
    Dik, Iskender
    Sander, Ersan
    Gucin, Zuhal
    ISTANBUL MEDICAL JOURNAL, 2006, 7 (03): : 1 - 4
  • [45] Combination of interferon induction therapy and ribavirin in chronic hepatitis C
    Ferenci, P
    Brunner, H
    Nachbaur, K
    Datz, C
    Gschwantler, M
    Hofer, H
    Stauber, R
    Hackl, F
    Jessner, W
    Rosenbeiger, M
    Munda-Steindl, P
    Hegenbarth, K
    Gangl, A
    Vogel, W
    HEPATOLOGY, 2001, 34 (05) : 1006 - 1011
  • [46] Combination therapy with ribavirin plus alpha-interferon for the treatment of chronic hepatitis C in naive patients and use of Beck depression inventory.
    Kwo, PY
    Fields, S
    Born, L
    Chalasani, N
    Cho, W
    Crabb, DW
    Cummings, OW
    Imperiale, T
    Krause, AK
    Lumeng, L
    McGill, JM
    Ness, R
    Callon, R
    Pintozzi, R
    Jones, B
    Lansford, C
    Pappas, SC
    Rusche, HF
    Maier, J
    Isenberg, M
    HEPATOLOGY, 1998, 28 (04) : 282A - 282A
  • [47] Secondary adjunction of ribavirin after six months of alpha interferon therapy increases the sustained response rate in naive patients with chronic hepatitis C.
    Wartelle-Bladou, C
    Arpurt, JP
    Glibert, A
    Renou, C
    Pariente, A
    Pillon, D
    Picon, M
    Nalet, B
    Chousterman, M
    Grasset, D
    HEPATOLOGY, 2001, 34 (04) : 334A - 334A
  • [48] Alpha-interferon with ribavirin for the treatment of chronic hepatitis C in treatment naive patients.
    Kwo, PY
    Fields, S
    Chalasani, N
    Cho, W
    Crabb, DW
    Cummings, OW
    Imperiale, T
    McGill, JM
    Ness, R
    Pound, D
    Pintozzi, R
    Lansford, C
    GASTROENTEROLOGY, 2000, 118 (04) : A1459 - A1459
  • [49] Daily use of ribavirin-interferon combination in earlier non-responder or relapser patients with chronic hepatitis C.
    Karasu, Z
    Gurakar, A
    Jazzar, A
    McMillon, G
    Hulagu, S
    Wright, H
    HEPATOLOGY, 1999, 30 (04) : 629A - 629A
  • [50] The combination or interferon plus ribavirin is the therapy of choice for naive patients with chronic hepatitis C, based on economic grounds.
    Buti, M
    Casado, MA
    Fosbrook, L
    Esteban, R
    HEPATOLOGY, 1999, 30 (04) : 366A - 366A
12345